CL2013001999A1 - Metodo de preparacion de un gel de colageno reticulado por radiacion que comprende la irradiacion del colageno liquido con radiacion para asi obtener un colageno reticulado; gel de colageno; y uso. - Google Patents

Metodo de preparacion de un gel de colageno reticulado por radiacion que comprende la irradiacion del colageno liquido con radiacion para asi obtener un colageno reticulado; gel de colageno; y uso.

Info

Publication number
CL2013001999A1
CL2013001999A1 CL2013001999A CL2013001999A CL2013001999A1 CL 2013001999 A1 CL2013001999 A1 CL 2013001999A1 CL 2013001999 A CL2013001999 A CL 2013001999A CL 2013001999 A CL2013001999 A CL 2013001999A CL 2013001999 A1 CL2013001999 A1 CL 2013001999A1
Authority
CL
Chile
Prior art keywords
collagen
radiation
crosslinked
gel
irradiation
Prior art date
Application number
CL2013001999A
Other languages
English (en)
Inventor
Ji Chul Yu
Se Ken Yeo
Tai Hyoung Kim
Dong Sam Shu
Cheong Ho Chang
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of CL2013001999A1 publication Critical patent/CL2013001999A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
CL2013001999A 2011-01-19 2013-07-08 Metodo de preparacion de un gel de colageno reticulado por radiacion que comprende la irradiacion del colageno liquido con radiacion para asi obtener un colageno reticulado; gel de colageno; y uso. CL2013001999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110005588A KR101272484B1 (ko) 2011-01-19 2011-01-19 방사선 가교화된 콜라겐 겔 및 그 제조방법과 사용방법

Publications (1)

Publication Number Publication Date
CL2013001999A1 true CL2013001999A1 (es) 2014-04-04

Family

ID=46515897

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001999A CL2013001999A1 (es) 2011-01-19 2013-07-08 Metodo de preparacion de un gel de colageno reticulado por radiacion que comprende la irradiacion del colageno liquido con radiacion para asi obtener un colageno reticulado; gel de colageno; y uso.

Country Status (22)

Country Link
US (1) US20130287746A1 (es)
EP (1) EP2666462B1 (es)
JP (2) JP6104818B2 (es)
KR (1) KR101272484B1 (es)
CN (1) CN103402489B (es)
AU (1) AU2011355853B2 (es)
BR (1) BR112013018508B1 (es)
CA (1) CA2823686C (es)
CL (1) CL2013001999A1 (es)
CY (1) CY1120157T1 (es)
DK (1) DK2666462T3 (es)
ES (1) ES2668783T3 (es)
HR (1) HRP20180619T1 (es)
HU (1) HUE037171T2 (es)
LT (1) LT2666462T (es)
MX (1) MX348572B (es)
NO (1) NO2666462T3 (es)
PL (1) PL2666462T3 (es)
PT (1) PT2666462T (es)
SG (1) SG192023A1 (es)
SI (1) SI2666462T1 (es)
WO (1) WO2012099293A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150053606A (ko) * 2013-11-08 2015-05-18 세원셀론텍(주) 콜라겐과 히알루론산의 천연가교를 통한 고무성질의 물성이 강화된 생체재료물질 및 그 제조방법
KR101523878B1 (ko) * 2014-03-26 2015-05-29 주식회사 엘앤씨바이오 입자형 무세포 진피와 히알루론산이 가교된 생체 이식용 조성물의 제조방법
KR101650273B1 (ko) * 2014-06-11 2016-08-23 주식회사 엘앤씨바이오 무세포 진피의 가교 및 생체 이식 또는 삽입용 조성물의 제조방법
KR101582660B1 (ko) * 2014-07-14 2016-01-08 한국원자력연구원 방사선을 이용한 콜라겐 함유 하이드로겔 마스크 팩 제조
KR101669478B1 (ko) 2015-11-23 2016-10-26 세원셀론텍(주) 콜라겐의 수득율을 높이는 방법
WO2017205740A1 (en) * 2016-05-26 2017-11-30 Integra Lifesciences Corporation Process for preparing tissue regeneration matrix
KR101861814B1 (ko) * 2016-06-08 2018-05-29 한국원자력연구원 이온 전도성 실리콘 하이드로겔과 이의 제조방법
JP7156665B2 (ja) * 2017-06-13 2022-10-19 国立研究開発法人量子科学技術研究開発機構 医薬、並びにその製造方法
JP6995437B2 (ja) * 2017-11-10 2022-02-04 多木化学株式会社 コラーゲン－コンドロイチン硫酸のゲル材料
KR102157742B1 (ko) * 2018-01-16 2020-09-18 한국원자력연구원 장기 유착 방지용 수화겔의 제조방법, 이를 이용한 수화겔, 필름 및 다공성 재료
TW202016288A (zh) * 2018-06-29 2020-05-01 國立研究開發法人量子科學技術研究開發機構 細胞培養用水凝膠、凝膠套組、細胞培養物之製造方法、及細胞培養用水凝膠之製造方法
CN109762184B (zh) * 2019-02-12 2022-03-08 河北考力森生物科技有限公司 一种胶原蛋白水凝胶的制备方法
CN112717200B (zh) * 2021-01-13 2022-06-07 常州市中辉医疗器械有限公司 一种重组人胶原蛋白可吸收水凝胶皮肤支架及其制备方法、使用方法
CN113842502B (zh) * 2021-09-29 2022-12-02 西安德诺海思医疗科技有限公司 一种含有去蛋白骨的注射填充剂及其制备方法
CN114085394B (zh) * 2021-12-16 2023-04-18 西安德诺海思医疗科技有限公司 一种重组胶原蛋白双相凝胶及其制备方法和应用
KR102466953B1 (ko) 2022-04-14 2022-11-15 주식회사 제브 전자빔 조사에 의한 가교 구조 제어를 이용한 하이드로겔 제조방법과 이에 의해 제조된 천연다당류 하이드로겔
CN117327300A (zh) * 2023-08-29 2024-01-02 江苏艾玮得生物科技有限公司 水凝胶及其制备方法、类器官及其培养方法、药物检测的方法
CN117298327A (zh) * 2023-11-15 2023-12-29 北京帝康医药投资管理有限公司 一种止血微球颗粒及其制备方法和应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223984A (en) * 1979-04-04 1980-09-23 Opticol Corporation Collagen soft contact lens
US4268131A (en) * 1979-04-11 1981-05-19 Opticol Corporation Fiber collagen contact lens
US4452925A (en) * 1981-02-09 1984-06-05 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
FR2601371B1 (fr) * 1986-07-11 1989-05-12 Merieux Inst Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede
US5634943A (en) * 1990-07-12 1997-06-03 University Of Miami Injectable polyethylene oxide gel implant and method for production
US5209776A (en) * 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5376117A (en) * 1991-10-25 1994-12-27 Corvita Corporation Breast prostheses
US5800537A (en) * 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
US5836313A (en) * 1993-02-08 1998-11-17 Massachusetts Institute Of Technology Methods for making composite hydrogels for corneal prostheses
JPH08308562A (ja) * 1995-05-16 1996-11-26 Sumitomo Bakelite Co Ltd 動物細胞培養器及びそれを用いる薬物代謝活性の測定方法
JPH09122227A (ja) * 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料およびその製造方法
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
AU4648697A (en) * 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
JPH11137662A (ja) * 1997-11-11 1999-05-25 Terumo Corp 放射線滅菌されたコラーゲンゲル及びその製造方法
JP2000107278A (ja) * 1998-10-06 2000-04-18 Terumo Corp 皮膚潰瘍補填修復材料
US6958149B2 (en) * 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
JP2000135275A (ja) * 1998-10-30 2000-05-16 Menicon Co Ltd 人工皮膚基材又は細胞培養用基材の滅菌方法
JP4596341B2 (ja) * 1999-11-11 2010-12-08 オリンパステルモバイオマテリアル株式会社 液体状創傷被覆材
JP2002145753A (ja) * 2000-11-06 2002-05-22 Orbis Inc 保湿用組成物及び該組成物を含有する化粧料
TWI245634B (en) * 2001-12-28 2005-12-21 Ind Tech Res Inst Preparation of a biodegradable thermal-sensitive gel system
CN1169874C (zh) * 2002-06-21 2004-10-06 华南理工大学 生物活性聚乙烯醇／羟基磷灰石纳米复合水凝胶及制备方法
JP2004250395A (ja) * 2003-02-21 2004-09-09 Roakosumo:Kk 生体活性組成物
IL155866A0 (en) * 2003-05-12 2003-12-23 Yissum Res Dev Co Responsive polymeric system
CN101570339A (zh) 2004-03-15 2009-11-04 昭和电工株式会社 圆形熔融氧化铝颗粒、其生产方法和包含该颗粒的树脂组合物
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
KR20060082207A (ko) * 2005-01-11 2006-07-18 장동섭 충진재 배출장치
US20060229492A1 (en) * 2005-04-08 2006-10-12 G & L Consulting Llc Materials and methods for in situ formation of a heart constrainer
WO2007043255A1 (ja) * 2005-09-13 2007-04-19 Arblast Co., Ltd. 培養角膜内皮シート及びその作製方法
JP2007182407A (ja) * 2006-01-10 2007-07-19 Medgel Corp 徐放性ハイドロゲル製剤
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
JPWO2008016163A1 (ja) * 2006-08-01 2009-12-24 ニチバン株式会社 架橋ゼラチンゲル多層構造体、生理活性因子用担体、生理活性因子放出用製剤、及びこれらの製造方法
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
KR100783228B1 (ko) * 2006-08-29 2007-12-06 가톨릭대학교 산학협력단 세포배양용 폴리비닐알코올-콜라겐 하이드로젤 스캐폴드 및그 제조방법
KR100837858B1 (ko) 2006-12-18 2008-06-13 한국식품연구원 방사선 조사에 의한 돈피 콜라겐의 수용성 올리고펩타이드의 제조방법
JP5099623B2 (ja) * 2007-03-01 2012-12-19 独立行政法人日本原子力研究開発機構 免疫蛋白質の製造方法
KR100848712B1 (ko) * 2007-03-30 2008-07-28 강원대학교산학협력단 광가교 가능한 온도 감응성 수화겔 조성물 및 이의제조방법
EP2238163A1 (en) * 2008-01-31 2010-10-13 Sofradim Production Preparation of terminally-sterilized collagen that is soluble at neutral ph

Also Published As

Publication number Publication date
BR112013018508A2 (pt) 2019-01-08
EP2666462A4 (en) 2016-03-09
JP6228960B2 (ja) 2017-11-08
KR101272484B1 (ko) 2013-06-10
JP6104818B2 (ja) 2017-04-05
CA2823686A1 (en) 2012-07-26
EP2666462A1 (en) 2013-11-27
JP2016052314A (ja) 2016-04-14
CY1120157T1 (el) 2018-12-12
MX2013008467A (es) 2013-08-12
HUE037171T2 (hu) 2018-08-28
BR112013018508B1 (pt) 2020-03-10
ES2668783T3 (es) 2018-05-22
HRP20180619T1 (hr) 2018-06-01
AU2011355853A1 (en) 2013-08-15
SG192023A1 (en) 2013-08-30
CN103402489B (zh) 2016-05-11
NO2666462T3 (es) 2018-09-08
PL2666462T3 (pl) 2018-07-31
JP2014507135A (ja) 2014-03-27
CN103402489A (zh) 2013-11-20
KR20120084189A (ko) 2012-07-27
AU2011355853B2 (en) 2016-04-21
CA2823686C (en) 2017-09-05
LT2666462T (lt) 2018-05-25
US20130287746A1 (en) 2013-10-31
PT2666462T (pt) 2018-05-16
WO2012099293A1 (ko) 2012-07-26
MX348572B (es) 2017-06-15
EP2666462B1 (en) 2018-04-11
SI2666462T1 (en) 2018-06-29
DK2666462T3 (en) 2018-05-22

Similar Documents

Publication Publication Date Title
CL2013001999A1 (es) Metodo de preparacion de un gel de colageno reticulado por radiacion que comprende la irradiacion del colageno liquido con radiacion para asi obtener un colageno reticulado; gel de colageno; y uso.
BR112016011983A2 (pt) Painel, painel laminado, arranjo de painel, método para produzir o painel e uso do painel
CL2016000507A1 (es) Hidrogel que comprende los grupos 1, 2-diol o 1, 3-diol acetilados con una especie radiopaca; composición que comprende un hidrogel; método para realizar un polímero radiopaco; método para formar una microesfera de hidrogel radiopaca; y uso de hidrogel o composición.
CL2013002195A1 (es) Miméticos de las moléculas mir-34a y mir-34c, composiciones farmacéuticas que los comprenden, y su uso para inhibir la proliferación celular e inducir apoptosis de células cancerosas.
CL2015000092A1 (es) Oligonucleótidos quiralmente controlados, composición que los comprende; método de elaboración: y uso para tratar cáncer.
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
NI201400125A (es) Antagonistas de st2l y métodos de uso
EP3080440A4 (en) Multi-directional wave energy absorption converter absorption
BR112014030275A2 (pt) método para obter um material sólido com base em um polímero, material sólido, e, uso de material sólido.
BR112015006652A2 (pt) método e sistema para procedimentos cosméticos de pele para uso doméstico.
BR112015002091A2 (pt) método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
BR112014004930A2 (pt) processo para a produção de olefinas, e, uso das olefinas
BR112013006092A2 (pt) laminado, matéria-prima do laminado, método para preparação de um laminado e uso do laminado
PL2871466T3 (pl) Budowa suwnicy bramowej do użycia w złożonym ruchomym systemie kontroli promieniowania
CL2014002183A1 (es) Polipeptidos de factor ix modificado con ctp; polinucleotido que lo codifica; composicion que lo comprende; usos y metodo para tratar hemofilia; factores de coagulacion modificados con ctp y sus usos.
BR112015002464A2 (pt) processo para a preparação de carbamat-benzoxazinonas, carbamat-benzoxazinonas e utilização das carbamat-benzoxazinonas
BR112015008113A2 (pt) novo processo para preparar compostos para uso no tratamento de câncer.
BR112015021707A2 (pt) uso de células de planta que expresam um inibidor de polipeptídeo tnfalfa em terapia.
CO6870047A2 (es) Soporte basado en fibras celulósicas y/o sintéticas, método para producirlo y uso del soporte
BR112014026564A2 (pt) formulação, uso de uma formulação, e, processo para a preparação de uma formulação
BR112014026565A2 (pt) formulação, uso de uma formulação, e, processo para produzir uma formulação
SG11201601105SA (en) Composite ionic liquid catalyst
CL2016000998A1 (es) Composición herbaria, procedimiento para su preparación y uso de la misma
BR112014028753A2 (pt) processo para umedecer com água superfícies umedecidas com óleo.
CL2015001681A1 (es) Unidad solida con alto contenido en fexofenadina; procedimiento de preparacion; y uso de la misma como antihistaminico, broncodilatador y/o para el tratamiento de alergias y/o urticarias.